Atul Pande
Director · Immunovant, Inc.
IndividualSelling only16 10b5-1 trades
- 2024
- Aug 28, 2026
- 7
Filings (90d)
2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Atul Pande files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Andrew J. Fromkin - $7.96M in IMVT purchases and sales in the last 12 months
- Jay S. Stout - $2.34M in IMVT purchases and sales in the last 12 months
- Melanie Gloria - $1.67M in IMVT purchases and sales in the last 12 months
- Tiago Girao - $1.41M in IMVT purchases and sales in the last 12 months
- Tuyl Christopher van - $1.17M in IMVT purchases and sales in the last 12 months
- Eric Venker - $581K in IMVT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Atul Pande?
Atul Pande is a corporate insider, tracked as Director of Immunovant, Inc. (IMVT). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Atul Pande submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Atul Pande been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($646K) across all tracked filings.
